Trial Profile

A Phase II/III Study of CS-8958 in Pediatric Patients -A randomized double-blind controlled study of CS-8958 comparing with oseltamivir phosphate in patients with influenza virus infection aged 9 years or younger

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 07 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Apr 2010 Results published in Antimicrobial agents and chemotherapy.
10 Aug 2009 Top-line results reported in a Biota Holdings media release.
10 Aug 2009 Data from this trial will be used in the NDA submission to the US FDA, according to a Daiichi Sankyo Company media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com